Patients with MM and APC/CTNNB1 genetic aberrations who have received PD1 inhibitors at some point during their disease’s natural history have a similar OS with that of patients without APC/CTNNB1 genetic aberrations. Here, CTNNB1 is linked to Miyoshi myopathy.